NCT00467428View on ClinicalTrials.gov

Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

September 30, 2004

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

NS2359

DRUG

Placebo

Trial Locations (1)

02114

Adult and Pediatric Psychopharmacology, Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

NeuroSearch A/S
All Listed Sponsors
lead

NeuroSearch A/S

INDUSTRY

NCT00467428 - Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder | Biotech Hunter | Biotech Hunter